Partners

In line with the FDFA Guidelines on Partnering with Sponsors to increase external transparency about the partnerships entered into by Switzerland’s embassies and consulates abroad, we are providing a list of the current-year sponsorship partners and the corresponding events.

For 2026, our confirmed partners are (last update on 13.08.2026):

Partner 

Event / Project

Swiss Cultural Fund

Autokomanda-Vozdovac Gallery

Swiss Cultural Fund

Belgrade Dance Festival

Swiss Cultural Fund

Jan Eugster Gallery

Swiss Cultural Fund

Art competition for the new Swiss Embassy Offices

Swiss Cultural Fund

Piano Quintet Concert “Five Ways”

Swiss Cultural Fund

Urban Laboratory

Swiss Cultural Fund

Festival of International Student Theatre

Swiss Cultural Fund

Balkan Love project

Swiss Cultural Fund

Guitar Art Summer Fest Herceg Novi

Swiss Cultural Fund

Lozionica Artist-in-Residence Program

Swiss Cultural Fund

Changeover festival

Swiss Cultural Fund

Metamodernism contemporary architecture

Swiss Cultural Fund

Festival Polja

Swiss Cultural Fund

10th Pančevo Film Festival

The Swiss Cultural Fund – Serbia

The Swiss Cultural Fund – Serbia was established by the Embassy of Switzerland in Serbia in September 2015 and is financed by contributions from sponsors. The aim of the fund is to promote cultural activities in Serbia and thereby to contribute to a positive image of Switzerland in Serbia and to the further intensification of the bilateral relations between both countries.

The following partners have financially contributed to the fund (2025-2026):

  1. MRG doo
  2. Jan Group / Serbia Prime Site One-SPSO
  3. Avolta AG (DUFRY)
  4. ROCHE
  5. Barry-Callebaut
  6. Stadler Rail
  7. MSC Mediterranean Shipping Company
  8. Regent Lighting
  9. Star-Import/ Emil Frey
  10. Lafarge Holcim
  11. Sky-Express doo
  12. Adecco doo Serbia
  13. Kühne & Nagel doo
  14. SGS Belgrade
  15. Gebrüder Weiss doo
  16. Omya Vencac doo
  17. Heitkamp Construction Swiss GmbH
  18. SICPA SA
  19. SIKA Serbia doo
  20. Novartis Pharma